Table 4B.
Dose (mg/kg) | Cycle | Aflibercept concentrations (ng/ml) | Free/Bound | |
---|---|---|---|---|
Free | Bound | |||
2.0 | Cycle 1, Day 8 (n=3) | 6.86 (6.16–7.56) | 2.50 (1.76–3.96) | 3.87 |
Cycle 2, Pretreatment (n=4) | 1.50 (0.12–3.43) | 3.61 (2.05–6.22) | 0.52 | |
Cycle 5, Pretreatmnt (n=3) | 4.20 (1.81–8.01) | 8.16 (4.47–13.20) | 0.43 | |
2.5 | Cycle 1, Day 8 (n=5) | 4.96 (3.33–6.02) | 2.39 (2.06–2.69) | 2.10 |
Cycle 2, Pretreatment (n=5) | 1.45 (0.99–2.01) | 3.35 | 0.44 | |
Cycle 5, Pretreatment (n=1) | 0.49 | 4.34 | 0.11 | |
3.0 | Cycle 1, Day 8 (n=4) | 7.46 (4.59–9.94) | 1.96 (1.78–2.21) | 3.88 |
Cycle 2, Pretreatment (n=6) | 2.20 (0.81–4.15) | 3.27 (2.79–3.84) | 0.71 | |
Cycle 5, Pretreatment (n=0) |
Values represent mean concentrations with range in parentheses.
NOTE: Cycle 1, Day 8- N=3, Cycle 2 Pretreatment- N=5 One patient had bound measurements at each time point, but free measurements only for the Cycle 5, pretreatment timepoint.